By: Jillian Wilson
A common diabetes drug may increase survival rates among women with ovarian cancer.
A mayo clinic study found diabetic patients with ovarian cancer who took Metformin for their diabetes were nearly four times more likely to survive compared to ovarian cancer patients who did not take the drug.
Previous research has shown the drug may also fight other cancers.
Researchers hope to start using the drug for large–scale trials in ovarian cancer.
The centers for disease control and prevention reports flu season is officially underway – the earliest start in nearly a decade.